Prognostic value of the initial chest high-resolution CT pattern in idiopathic pulmonary fibrosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 32, Issue 4, 2015, Pages 353-359

  Le Rouzic, Olivier ^a,b   Bendaoud, Sofiane ^a,b   Chenivesse, Cécile ^c   Remy, Jacques ^a,b   Wallaert, Benoît ^a,b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

High resolution computed tomography; Idiopathic pulmonary fibrosis; radiological diagnostic; Prognosis; Pulmonary function tests

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; AGE; DIAGNOSTIC IMAGING; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN MEIER METHOD; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; X-RAY COMPUTED TOMOGRAPHY;

AGE FACTORS; AGED; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84983150580     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011; 183: 788-824.
2. Pérez ERF, Daniels CE, Schroeder DR, St. Sauver J, Hartman TE, Bartholmai BJ, et al. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis. Chest 2010; 137: 129-37.
3. King Jr TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-61.
4. George TJ, Arnaoutakis GJ, Shah AS. Lung Transplant in Idiopathic Pulmonary Fibrosis. Arch Surg 2011; 146: 1204-9.
5. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med 2014; 370: 2083-2092.
6. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N Engl J Med 2014; 370: 2071-2082
7. Barlo NP, van Moorsel CHM, van den Bosch JMM, Grutters JC. Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 85-95.
8. Sverzellati N, Wells AU, Tomassetti S, Desai SR, Copley SJ, Aziz ZA, et al. Biopsy-proved Idiopathic Pulmonary Fibrosis: Spectrum of Nondiagnostic Thin-Section CT Diagnoses1. Radiology 2010; 254: 957-64.
9. Akira M, Inoue Y, Arai T, Okuma T, Kawata Y. Long-term followup high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61-5.
10. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143-8.
11. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al. Computed Tomography Findings in Pathological Usual Interstitial Pneumonia. Am J Respir Crit Care Med 2008; 177: 433-9.
12. Best AC, Meng J, Lynch AM, Bozic CM, Miller D, Grunwald GK, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 2008; 246: 935-40.
13. King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting Survival in Idiopathic Pulmonary Fibrosis . Scoring System and Survival Model. Am J Respir Crit Care Med 2001; 164: 1171-81.
14. Maldonado F, Moua T, Rajagopalan S, Karwoski RA, Raghunath S, Decker PA, et al. Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J 2014; 43: 204-12.
15. Shin KM, Lee KS, Chung MP, Han J, Bae YA, Kim TS, et al. Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. Radiology 2008; 249: 328-37.
16. Oda K, Ishimoto H, Yatera K, Naito K, Ogoshi T, Yamasaki K, et al. High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis. Respir Res 2014; 15: 10.
17. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
18. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2005; 172: 488-93.
19. Quadrelli S, Molinari L, Ciallella L, Spina JC, Sobrino E, Chertcoff J. Radiological versus histopathological diagnosis of usual interstitial pneumonia in the clinical practice: does it have any survival difference? Respiration 2010; 79: 32-7.
20. Park JH, Kim DS, Park I-N, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-11.
21. Du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2011; 184: 1382-9.
22. Wémeau-Stervinou L, Perez T, Murphy C, Polge A-S, Wallaert B. Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Respir Med 2012; 106: 564-70.
23. Du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference. Am J Respir Crit Care Med 2011; 183: 1231-7.
24. ATS Statement Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111-7.
25. King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting Survival in Idiopathic Pulmonary Fibrosis . Scoring System and Survival Model. Am J Respir Crit Care Med 2001; 164: 1171-81.
26. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011; 377: 1760-9.
27. Thomeer M, Demedts M, Behr J, Buhl R, Costabel U, Flower CDR, et al. Multidisciplinary Interobserver Agreement in the Diagnosis of Idiopathic Pulmonary Fibrosis. Eur Respir J 2008; 31: 585-91.
28. Hubbard R, Venn A, Lewis S, Britton J. Lung Cancer and Cryptogenic Fibrosing Alveolitis A Population-Based Cohort Study. Am J Respir Crit Care Med 2000; 161: 5-8.